Abstract:JOURNAL/nrgr/04.03/01300535-202508000-00031/figure1/v/2024-09-30T120553Z/r/image-tiff The protein connector enhancer of kinase suppressor of Ras 2 (CNKSR2), present in both the postsynaptic density and cytoplasm of neurons, is a scaffolding protein with several protein-binding domains. Variants of the CNKSR2 gene have been implicated in neurodevelopmental disorders, particularly intellectual disability, although the precise mechanism involved has not yet been fully understood. Research has demonstrated that CNKSR2 plays a role in facilitating the localization of postsynaptic density protein complexes to the membrane, thereby influencing synaptic signaling and the morphogenesis of dendritic spines. However, the function of CNKSR2 in the cytoplasm remains to be elucidated. In this study, we used immunoprecipitation and high-resolution liquid chromatography-mass spectrometry to identify the interactors of CNKSR2. Through a combination of bioinformatic analysis and cytological experiments, we found that the CNKSR2 interactors were significantly enriched in the proteome of the centrosome. We also showed that CNKSR2 interacted with the microtubule protein DYNC1H1 and with the centrosome marker CEP290. Subsequent colocalization analysis confirmed the centrosomal localization of CNKSR2. When we downregulated CNKSR2 expression in mouse neuroblastoma cells (Neuro 2A), we observed significant changes in the expression of numerous centrosomal genes. This manipulation also affected centrosome-related functions, including cell size and shape, cell proliferation, and motility. Furthermore, we found that CNKSR2 interactors were highly enriched in de novo variants associated with intellectual disability and autism spectrum disorder. Our findings establish a connection between CNKSR2 and the centrosome, and offer new insights into the underlying mechanisms of neurodevelopmental disorders.

CTNND2 regulation by the SRGAP2 protein family links human evolution to synaptic neoteny

CTNND2 moderates the pace of synaptic maturation and links human evolution to synaptic neoteny

Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition

Inhibition of SRGAP2 Function by Its Human-Specific Paralogs Induces Neoteny During Spine Maturation

Brain Developmental and Cortical Connectivity Changes in Transgenic Monkeys Carrying the Human-Specific Duplicated Gene SRGAP2C.

Rev or restrain: Mechanisms of human-specific synaptic neoteny

SYNGAP1 deficiency disrupts synaptic neoteny in xenotransplanted human cortical neurons in vivo

Human-specific paralogs of SRGAP2 induce neotenic features of microglia structural and functional maturation

Human SYNGAP1 Regulates the Development of Neuronal Activity by Controlling Dendritic and Synaptic Maturation

Hominini-specific regulation of <i>CBLN2</i> increases prefrontal spinogenesis

Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders

Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1- related intellectual disability

Syngap1 and the development of murine neocortical progenitor cells

Key roles of C2/GAP domains in SYNGAP1-related pathophysiology

A Novel CNTNAP2 Mutation Results in Abnormal Neuronal E/I Balance

A cross-species proteomic map reveals neoteny of human synapse development

Heterogeneous Clinical and Functional Features of GRIN2D-related Developmental and Epileptic Encephalopathy.

Compound heterozygous mutations of NTNG2 cause intellectual disability via inhibition of the CaMKII signaling

CNKSR2 interactome analysis indicates its association with the centrosome/microtubule system

Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice

Synaptic Protein DLG2 Controls Neurogenic Transcriptional Programs Disrupted in Schizophrenia and Related Disorders